mTOR activity (as assessed by the abundance of p-rpS6) was significantly higher in glioblastomas compared to anaplastic astrocytomas, while there was only a trend for higher proliferation (Ki67) in these tumors (Table II). This evidence concerns the gene RPS6 and glioblastoma.